Genetic Testing: The Next Frontier in Personalized GLP-1 Therapy PlexusDx's Precision Peptide Genetic Test represents a clinical advancement in matching patients to optimal weight loss compounds
"Because GLP1 affects so much the organism metabolic state, in ways that we do and do not understand, this is not extremely surprising." So far, it is not a side effect that has appeared in trials and it seems to mainly impact the wallet of those who experience it
This 3 3 phase 1 clinical trial assessed curcumin (1200 mg/day) and ursolic acid (300 mg/day), both alone and in combination, over 2 weeks, revealing no grade 3 or 4 adverse events, along with very minimal alterations in safety laboratory results
Hormonal imbalances, metabolic adaptations, stress, and environmental factors all play a role
"If newly identified safety signals are identified, the FDA will determine what, if any, actions are appropriate after a thorough review of available data." These actions may include requiring labeling changes or development of a Risk Evaluation and Mitigation Strategy, a program that helps ensure a medication's benefits outweigh its risks
.png)
